Pharmaceutical company: Generic competition weighs on Novartis
—·8h
Novartis achieved more sales in the second quarter. But the patent expiry of the heart drug Entresto is putting a strain on business.
Channelssemiconductors, stocksCountriesgermany, europeCategoriespharma
Open original source ↗Published
7/21/2026, 5:35:22 AM
Fetched
7/21/2026, 6:07:45 AM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
de